tetano
Editor, Senior Moderator
Exp Cell Res
. 2023 Nov 7:113853.
doi: 10.1016/j.yexcr.2023.113853. Online ahead of print. The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells
Matteo Zurlo[SUP] 1 [/SUP], Jessica Gasparello[SUP] 2 [/SUP], Marco Verona[SUP] 3 [/SUP], Chiara Papi[SUP] 2 [/SUP], Lucia Carmela Cosenza[SUP] 2 [/SUP], Alessia Finotti[SUP] 4 [/SUP], Giovanni Marzaro[SUP] 3 [/SUP], Roberto Gambari[SUP] 5 [/SUP]
Affiliations
The COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the ongoing coronavirus disease 2019 (COVID-19) pandemic. The SARS-CoV-2 Spike protein (S-protein) plays an important role in the early phase of SARS-CoV2 infection through efficient interaction with ACE2. The S-protein is produced by RNA-based COVID-19 vaccines, that were fundamental for the reduction of the viral spread within the population and the clinical severity of COVID-19. However, the S-protein has been hypothesized to be responsible for damaging cells of several tissues and for some important side effects of RNA-based COVID-19 vaccines. Considering the impact of COVID-19 and SARS-CoV-2 infection on the hematopoietic system, the aim of this study was to verify the effect of the BNT162b2 vaccine on erythroid differentiation of the human K562 cell line, that has been in the past intensively studied as a model system mimicking some steps of erythropoiesis. In this context, we focused on hemoglobin production and induced expression of embryo-fetal globin genes, that are among the most important features of K562 erythroid differentiation. We found that the BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation of K562 cells. Reverse-transcription-PCR and Western blotting assays demonstrated that suppression of erythroid differentiation was associated with sharp inhibition of the expression of α-globin and γ-globin mRNA accumulation. Inhibition of accumulation of ζ-globin and ε-globin mRNAs was also observed. In addition, we provide in silico studies suggesting a direct interaction between SARS-CoV-2 Spike protein and Hb Portland, that is the major hemoglobin produced by K562 cells. This study thus provides information suggesting the need of great attention on possible alteration of hematopoietic parameters following SARS-CoV-2 infection and/or COVID-19 vaccination.
Keywords: COVID-19 vaccine; Embryo-fetal hemoglobins; Erythroid differentiation; K562 cells; Mithramycin; SARS-CoV-2.
. 2023 Nov 7:113853.
doi: 10.1016/j.yexcr.2023.113853. Online ahead of print. The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells
Matteo Zurlo[SUP] 1 [/SUP], Jessica Gasparello[SUP] 2 [/SUP], Marco Verona[SUP] 3 [/SUP], Chiara Papi[SUP] 2 [/SUP], Lucia Carmela Cosenza[SUP] 2 [/SUP], Alessia Finotti[SUP] 4 [/SUP], Giovanni Marzaro[SUP] 3 [/SUP], Roberto Gambari[SUP] 5 [/SUP]
Affiliations
- PMID: 37944576
- DOI: 10.1016/j.yexcr.2023.113853
The COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the ongoing coronavirus disease 2019 (COVID-19) pandemic. The SARS-CoV-2 Spike protein (S-protein) plays an important role in the early phase of SARS-CoV2 infection through efficient interaction with ACE2. The S-protein is produced by RNA-based COVID-19 vaccines, that were fundamental for the reduction of the viral spread within the population and the clinical severity of COVID-19. However, the S-protein has been hypothesized to be responsible for damaging cells of several tissues and for some important side effects of RNA-based COVID-19 vaccines. Considering the impact of COVID-19 and SARS-CoV-2 infection on the hematopoietic system, the aim of this study was to verify the effect of the BNT162b2 vaccine on erythroid differentiation of the human K562 cell line, that has been in the past intensively studied as a model system mimicking some steps of erythropoiesis. In this context, we focused on hemoglobin production and induced expression of embryo-fetal globin genes, that are among the most important features of K562 erythroid differentiation. We found that the BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation of K562 cells. Reverse-transcription-PCR and Western blotting assays demonstrated that suppression of erythroid differentiation was associated with sharp inhibition of the expression of α-globin and γ-globin mRNA accumulation. Inhibition of accumulation of ζ-globin and ε-globin mRNAs was also observed. In addition, we provide in silico studies suggesting a direct interaction between SARS-CoV-2 Spike protein and Hb Portland, that is the major hemoglobin produced by K562 cells. This study thus provides information suggesting the need of great attention on possible alteration of hematopoietic parameters following SARS-CoV-2 infection and/or COVID-19 vaccination.
Keywords: COVID-19 vaccine; Embryo-fetal hemoglobins; Erythroid differentiation; K562 cells; Mithramycin; SARS-CoV-2.